Cite
HARVARD Citation
Watanabe, T. et al. (2016). A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma. British journal of haematology. pp. 745-756. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Watanabe, T. et al. (2016). A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma. British journal of haematology. pp. 745-756. [Online].